Acro
Username:
Password:



This text is replaced by the Flash movie.

ACRO (African Clinical Research Organisation) is the first South African, full-service, black economic empowerment, contract research organisation. We offer services both in Southern Africa and in other African regions.

The company was set up through collaboration between LIFElab, the commercial arm of the East Coast Biotechnology Innovation Centre, now incorporated into the Technology Innovation Agency (TIA) (a 3a Public Entity of the South African Government's Department of Science and Technology), and Batswadi Pharmaceuticals, a black-empowered company with a focus on biotechnology.

ACRO offers services to donor-funded organisations, non governmental organisations, research institutions, pharmaceutical companies, medical device companies, and government institutions, and work both within and outside the biotechnology sector. We are active across a broad range of clinical areas; an important aim of our organisation is to help improve the care of those affected by HIV/AIDS, tuberculosis, malaria, and other diseases prevalent in African populations.

ACRO News
  • ACRO Mandela Day 2016...
  • The Kilimanjaro Clinical Research Institute kindly made their premises available to African Clinical Research...
  • The FACTS Consortium will continue studying tenofovir gel for HIV and HSV-2 prevention in women
  • ACRO Training at the KCRI

African Clinical News

  • Experimental Ebola vaccine trials begin in Africa
  • Asbestos Related Diseases
  • A Road Less Travelled
  • R1bn pumped towards NHI
  • Paladin partners with Litha, aid merge of South African pharmas
  • eThekwini Hospital performs its first kidney transplant

Co Reg No. 2004/010364/07
VAT No. 4720239310
Tel +27 11 470 2800
Fax +27 11 470 2810
Phase III, 2nd Floor Offices
Centurion Science Park
1011 Pretorius Ave
Lyttelton Manor
Centurion, 0157
P.O. Box 688
Cramerview
2060
© Copyright 2017 ACRO
All Rights Reserved
PAIA   |   Contact Us   |    BBBEE Certificate   |    Links

Designed and developed by